Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Biphenotypic, Acute 1Down Syndrome 1Burkitt Lymphoma 1

Interventions

Methotrexate 7Cyclophosphamide 7Methylprednisolone 6merphos 5Cytarabine 5Asparaginase 5pegaspargase 4Vincristine 4Specimen Handling 4Mercaptopurine 4Leucovorin 4Dexamethasone 4Daunorubicin 4dexamethasone acetate 3dexamethasone 21-phosphate 3calaspargase pegol 3azathiopurine 3auricularum 3Thioguanine 3Prednisolone 3Hydrocortisone 3Etoposide 3Doxorubicin 3Calcium Dobesilate 3Antilymphocyte Serum 3prednylidene 2liposomal amphotericin B 2exifone 2deltacortene 2blinatumomab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Biphenotypic, Acute × Leyk × Clear all
NCT00557193 2024-07-15

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Completed
218 enrolled 21 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡